| Description | Date | Event Coding |
|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-10-03 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-11-16 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2020-11-17 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2021-02-24 | 4 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-02-24 | 5 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-03-10 | 6 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-03-30 | 7 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-03-30 | 8 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-05-25 | 9 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-11-18 | 10 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2021-11-18 | 11 EXT1 S: |
| EXTENSION 1 GRANTED | 2021-11-18 | 12 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-11-20 | 13 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-05-24 | 14 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2022-05-24 | 15 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2022-05-24 | 16 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-05-26 | 17 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-11-22 | 18 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2022-11-22 | 19 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2022-11-22 | 20 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-11-24 | 21 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-12-10 | 22 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-12-10 | 23 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-12-10 | 24 TCCA I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2023-02-15 | 25 ASGN I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2023-02-22 | 26 ASCK I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2023-04-25 | 27 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2023-04-25 | 28 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2023-04-25 | 29 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-04-27 | 30 EXRA E:E-Mail |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2023-06-14 | 31 ASCK I:Incoming Correspondence |
| SOU TEAS EXTENSION RECEIVED | 2023-10-03 | 32 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-10-12 | 33 AITU A:Allowance for Publication |
| SOU EXTENSION 5 FILED | 2023-10-03 | 34 EXT5 S: |
| SOU EXTENSION 5 GRANTED | 2023-10-12 | 35 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-10-13 | 36 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2024-07-01 | 37 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2024-07-12 | 38 MAB6 E:E-Mail |
Mylan Pharmaceuticals, Inc.
| 